Sunwin International Neutraceuticals, Inc. to Present at Dutton Associates' "Recognizing Opportunity" Health Sciences SmallCap Conference in San Francisco May 31

Market Wire, May, 2006

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, today announced its US representative will present at Dutton Associates' "Recognizing Opportunity" Health Sciences SmallCap Conference. Our US representative along with a select group of emerging growth healthcare, healthcare services, biotechnology, medical devices, and pharmaceutical companies will update investment professionals on business activities, trends and current developments.

The conference will take place at St. Regis Hotel in San Francisco on Wednesday, May 31 from 7:45 a.m. to 5 p.m. Our US representative will make one ten-minute presentation in the morning, which will be webcast and available on May 31, 2006 and thereafter on www.jmdutton.com . In the afternoon, our US representative will present to small, informal groups of investment professionals during two break-out sessions. For more conference information and registration, visit www.jmdutton.com .

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received an award as one of Shandong's Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz

About Dutton Associates

Dutton Associates, an international issuer-paid equity research firm, offers independent, fundamental research on over 120 small cap public companies. The company's 29 analysts are primarily CFA charter holders with, on average, over 20 years of experience at the major securities firms, and provide research coverage on over 120 companies. For more information, please visit www.jmdutton.com .

Contact: Jimmy Glickstein Telephone: 1-877-China-57 Email: info@sunwin.biz